The role of levocarnitine in the systemic therapy of patients of different profile of patients on chronic hemodialysis
Journal Title: Нирки - Year 2014, Vol 1, Issue 7
Abstract
the paper presents the pharmacological characteristics of L-carnitine and evaluation of the effectiveness of its application in nephrology practice. Discussed the evidence of the use of levocarnitine for chronic kidney disease and chronic renal failure
Authors and Affiliations
A. M. Ivanova, O. O. Bogomolets
Keywords
Related Articles
- EP ID EP225233
- DOI -
- Views 108
- Downloads 0
American Diabetes Association Standards of Medical Care in Diabetes — 2018 Diabetes Care. — 2018 Jan. — 41(S. 1). — https://doi.org/10.2337/dc18-Sint01.
.
Drug Treatment of Diabetic Nephropathy on Hyperfiltration Stage
In the article deals with the problem of early clinical diagnosis markers of diabetic kidney disease, namely hyperfiltration and renal functional reserve, reflecting first structural and functional changes in patients w...
Endothelial dysfunction in the pathogenesis of diabetic kidney disease
The article deals with the integrated characteristics of hyperglycemia role in the pathogenesis of vascular complications of diabetes mellitus. The article analyzes the modern data on the mechanisms of development and pr...
Hepatitis C virus Infection in Nephrology Patients
Hepatitis C virus (HCV) infection leads to chronic liver disease, but also to extra-hepatic manifestations [1]. These include mixed cryoglobulinemia, lymphoproliferative disorders, and renal disease. HCV infection has be...
Commentary on the KDIGO Guideline on the Diagnosis, Evaluation, Prevention and Treatment of CKD-MBD, 2018
.